SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-284964
Filing Date
2021-09-28
Accepted
2021-09-28 08:41:56
Documents
14
Period of Report
2021-09-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d234235d8k.htm   iXBRL 8-K 28730
2 EX-99.1 d234235dex991.htm EX-99.1 7146
6 GRAPHIC g234235g0927091024356.jpg GRAPHIC 2716
  Complete submission text file 0001193125-21-284964.txt   166513

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alec-20210923.xsd EX-101.SCH 2876
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alec-20210923_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alec-20210923_pre.xml EX-101.PRE 11397
7 EXTRACTED XBRL INSTANCE DOCUMENT d234235d8k_htm.xml XML 3334
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 211283713
SIC: 2836 Biological Products, (No Diagnostic Substances)